Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct;16(5):538-42.
doi: 10.1089/sur.2014.162. Epub 2015 Jun 25.

The Natural Surfactant Glycerol Monolaurate Significantly Reduces Development of Staphylococcus aureus and Enterococcus faecalis Biofilms

Affiliations

The Natural Surfactant Glycerol Monolaurate Significantly Reduces Development of Staphylococcus aureus and Enterococcus faecalis Biofilms

Donavon J Hess et al. Surg Infect (Larchmt). 2015 Oct.

Abstract

Background: Bacterial biofilms are involved in a large proportion of clinical infections, including device-related infections. Unfortunately, biofilm-associated bacteria are typically less susceptible to antibiotics, and infected devices must often be removed. On the basis of a recent observation that lipid-rich biofilm matrix material is present in early biofilm formation and may protect a population of bacteria from interacting with ordinarily diffusible small molecules, we hypothesized that surfactants may be useful in preventing biofilm development.

Methods: Experimental Staphylococcus aureus or Enterococcus faecalis biofilms were cultivated on surgical suture suspended in a growth medium supplemented with the natural surfactant glycerol monolaurate (GML) or with a component molecule, lauric acid. After 16 h incubation, the numbers of viable biofilm-associated bacteria were measured by standard microbiologic techniques and biofilm biomass was measured using the colorimetric crystal violet assay.

Results: Both GML and lauric acid were effective in inhibiting biofilm development as measured by decreased numbers of viable biofilm-associated bacteria as well as decreased biofilm biomass. Compared with lauric acid on a molar basis, GML represented a more effective inhibitor of biofilms formed by either S. aureus or E. faecalis.

Conclusions: Because the natural surfactant GML inhibited biofilm development, resulting data were consistent with the hypothesis that lipids may play an important role in biofilm growth, implying that interfering with lipid formation may help control development of clinically relevant biofilms.

PubMed Disclaimer

Figures

<b>FIG. 1.</b>
FIG. 1.
Effect of glycerol monolaurate (GML) on development of Staphylococcus aureus RN 6390 and ATCC 25923 biofilms incubated 16 h on silk suture, as measured by the numbers of viable biofilm bacteria (A) and biofilm biomass (B). Each data point represents 12 biofilms. Dashed line represents the lower limit of assay detection. *, decreased at p<0.01 compared with corresponding 0 mM GML.
<b>FIG. 2.</b>
FIG. 2.
Phase contrast micrographs of silk suture incubated 16 h with Staphlococcus aureus RN 6390 cultivated in growth medium alone (A) or in growth medium supplemented with 0.35 mM GML (B). Scale bar is 200 μm.
<b>FIG. 3.</b>
FIG. 3.
Effect of lauric acid on development of Staphylococcus aureus RN 6390 and ATCC 25923 biofilms incubated 16 h on silk suture, as measured by the numbers of viable biofilm bacteria (A) and biofilm biomass (B). Each data point represents 12 biofilms. Dashed line represents the lower limit of assay detection. *, decreased at p<0.01 compared with corresponding 0 mM lauric acid.
<b>FIG. 4.</b>
FIG. 4.
Effect of glycerol monolaurate (GML) (A) and lauric acid (B) on development of Enterococcus faecalis OG1RF and VA1128 biofilms incubated 16 h on silk suture, as measured by the numbers of viable biofilm bacteria. Each data point represents 8 biofilms. Dashed line represents the lower limit of assay detection. *, decreased at p<0.01 compared with corresponding 0 mM GML or lauric acid.

Similar articles

Cited by

References

    1. Fux CA, Costerton JW, Stewart PS, et al. . Survival strategies of infectious biofilms. Trends Microbiol 2005;13:34–40 - PubMed
    1. Cos P, Tote K, Horemans T, Maes L. Biofilms: An extra hurdle for effective antimicrobial therapy. Curr Pharm Des 2010;16:2279–2295 - PubMed
    1. Flemming H-C, Wingender J. The biofilm matrix. Nat Rev 2010;8:623–633 - PubMed
    1. Flemming H-C, Neu TR, Wozniak DJ. The EPS matrix: The house of biofilm cells. J Bacteriol 2007;198:7945–7947 - PMC - PubMed
    1. Stewart PS, Franklin MJ. Physiological heterogeneity in biofilms. Nat Rev Microbiol 2008;6:199–210 - PubMed

Publication types

MeSH terms